Overview

ESCAPE Migraine Trial

Status:
Terminated
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this two arm controlled double-blind study is to determine the safety and effectiveness of PFO closure (closing a hole in the wall of the heart) in reducing the frequency of migraine headaches, in patients who experience migraine headaches and have a PFO, compared to medical therapy alone.
Phase:
Phase 3
Details
Lead Sponsor:
Abbott Medical Devices
St. Jude Medical